Drug Markets/Levorphanol Tartrate

Levorphanol Tartrate

6 NDCs across 6 manufacturers|6 Generic,0 Brand

Levorphanol Tartrate is used to treat pain, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 19, 1991, and the first generic was approved Mar 31, 2000. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $14 million on Levorphanol Tartrate across 4,464 claims for 692 beneficiaries.

Levorphanol Tartrate is available as 6 NDCs from 6 manufacturers (6 generic, 0 brand), with NADAC prices from $10.65 to $10.65 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

6

6G / 0B

Manufacturers

6

competing in market

Price Spread

$10.65 – $10.65

per EA

7d Activity

6 flat

avg +0.0% WoW · of 6 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

6 NDCs total, 6 shown

Frequently Asked Questions

What is Levorphanol Tartrate used to treat?

Levorphanol Tartrate is used to treat pain, per the National Library of Medicine's MED-RT classification.

When did Levorphanol Tartrate become available as a generic?

FDA approved the first generic Levorphanol Tartrate (ANDA) on Mar 31, 2000. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Levorphanol Tartrate?

In 2024, Medicare Part D spent $14 million on Levorphanol Tartrate across 4,464 claims for 692 beneficiaries.

How many Levorphanol Tartrate products are on the market?

The Levorphanol Tartrate drug market contains 6 NDCs from 6 manufacturers — 6 generic and 0 brand products.

What is the price range for Levorphanol Tartrate?

NADAC reference prices for Levorphanol Tartrate range from $10.6456 to $10.6456 per EA.

Which manufacturers make Levorphanol Tartrate?

6 manufacturers list Levorphanol Tartrate in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (1), Hikma Pharmaceuticals USA Inc. (1), Virtus Pharmaceuticals, LLC (1), SpecGx LLC (1), Acertis Pharmaceuticals, LLC (1).